Association between CYP2D6 genotype and tamoxifen-induced hot flashes in a prospective cohort N Lynn Henry, JM Rae, L Li, F Azzouz, TC Skaar, Z Desta, MJ Sikora, ... Breast cancer research and treatment 117, 571-575, 2009 | 82 | 2009 |
Genetic associations with toxicity-related discontinuation of aromatase inhibitor therapy for breast cancer NL Henry, TC Skaar, J Dantzer, L Li, K Kidwell, C Gersch, AT Nguyen, ... Breast cancer research and treatment 138, 807-816, 2013 | 59 | 2013 |
An integrated pharmacokinetics ontology and corpus for text mining HY Wu, S Karnik, A Subhadarshini, Z Wang, S Philips, X Han, C Chiang, ... BMC bioinformatics 14, 1-15, 2013 | 57 | 2013 |
Estrogen receptor genotypes influence hot flash prevalence and composite score before and after tamoxifen therapy Y Jin, DF Hayes, L Li, JD Robarge, TC Skaar, S Philips, A Nguyen, ... Journal of Clinical Oncology 26 (36), 5849, 2008 | 53 | 2008 |
Identification of genetic variants in the human indoleamine 2, 3-dioxygenase (IDO1) gene, which have altered enzyme activity M Arefayene, S Philips, D Cao, S Mamidipalli, Z Desta, DA Flockhart, ... Pharmacogenetics and genomics 19 (6), 464-476, 2009 | 42 | 2009 |
Associations between genetic variants and the effect of letrozole and exemestane on bone mass and bone turnover S Oesterreich, NL Henry, KM Kidwell, CH Van Poznak, TC Skaar, ... Breast cancer research and treatment 154, 263-273, 2015 | 40 | 2015 |
Age‐related changes in MicroRNA expression and pharmacogenes in human liver KS Burgess, S Philips, EA Benson, Z Desta, A Gaedigk, R Gaedigk, ... Clinical Pharmacology & Therapeutics 98 (2), 205-215, 2015 | 40 | 2015 |
Regulation of microRNA expression by rifampin in human hepatocytes A Ramamoorthy, Y Liu, S Philips, Z Desta, H Lin, C Goswami, A Gaedigk, ... Drug Metabolism and Disposition 41 (10), 1763-1768, 2013 | 40 | 2013 |
The impact of glucocorticoid polymorphisms on markers of neonatal respiratory disease after antenatal betamethasone administration DM Haas, J Dantzer, AS Lehmann, S Philips, TC Skaar, CL McCormick, ... American journal of obstetrics and gynecology 208 (3), 215. e1-215. e6, 2013 | 33 | 2013 |
Genetic variation in DNA-repair pathways and response to radiochemotherapy in esophageal adenocarcinoma: a retrospective cohort study of the Eastern Cooperative Oncology Group HH Yoon, PJ Catalano, KM Murphy, TC Skaar, S Philips, M Powell, ... BMC cancer 11, 1-8, 2011 | 33 | 2011 |
Aromatase inhibitor-induced modulation of breast density: clinical and genetic effects NL Henry, HP Chan, J Dantzer, CP Goswami, L Li, TC Skaar, JM Rae, ... British journal of cancer 109 (9), 2331-2339, 2013 | 31 | 2013 |
CYP2D6 genotype is not associated with survival in breast cancer patients treated with tamoxifen: results from a population-based study DL Hertz, KM Kidwell, SG Hilsenbeck, S Oesterreich, CK Osborne, ... Breast cancer research and treatment 166, 277-287, 2017 | 30 | 2017 |
Functional Characterization of a Genetic Polymorphism in the Promoter of the ESR2 Gene S Philips, A Richter, S Oesterreich, JM Rae, DA Flockhart, NB Perumal, ... Hormones and Cancer 3, 37-43, 2012 | 29 | 2012 |
The impact of drug metabolizing enzyme polymorphisms on outcomes after antenatal corticosteroid use DM Haas, AS Lehmann, T Skaar, S Philips, CL McCormick, K Beagle, ... American journal of obstetrics and gynecology 206 (5), 447. e17-447. e24, 2012 | 27 | 2012 |
Association of variants in candidate genes with lipid profiles in women with early breast cancer on adjuvant aromatase inhibitor therapy CA Santa-Maria, A Blackford, AT Nguyen, TC Skaar, S Philips, ... Clinical Cancer Research 22 (6), 1395-1402, 2016 | 24 | 2016 |
A SNP in steroid receptor coactivator-1 disrupts a GSK3β phosphorylation site and is associated with altered tamoxifen response in bone RJ Hartmaier, AS Richter, RM Gillihan, JZ Sallit, SE McGuire, J Wang, ... Molecular Endocrinology 26 (2), 220-227, 2012 | 20 | 2012 |
Identification of germline cancer predisposition variants during clinical ctDNA testing LA Stout, N Kassem, C Hunter, S Philips, M Radovich, BP Schneider Scientific reports 11 (1), 13624, 2021 | 19 | 2021 |
Estrogen receptor genotypes, menopausal status, and the effects of tamoxifen on lipid levels: revised and updated results DF Hayes, TC Skaar, JM Rae, NL Henry, AT Nguyen, V Stearns, L Li, ... Clinical Pharmacology & Therapeutics 88 (5), 626-629, 2010 | 19 | 2010 |
Lack of association between oestrogen receptor polymorphisms and change in bone mineral density with tamoxifen therapy NL Henry, A Nguyen, F Azzouz, L Li, J Robarge, S Philips, D Cao, ... British journal of cancer 102 (2), 294-300, 2010 | 18 | 2010 |
Efficacy of nivolumab in pediatric cancers with high mutation burden and mismatch repair deficiency A Das, U Tabori, LC Sambira Nahum, NB Collins, R Deyell, R Dvir, ... Clinical Cancer Research 29 (23), 4770-4783, 2023 | 15 | 2023 |